Key result
Targeting metabolism via CPT1 inhibition shows potential for post-injury cardiac regeneration but lacks clinical data.
Why the study?
Heart failure is a leading cause of death due to the adult mammalian heart's inability to regenerate after injury, making novel regenerative approaches crucial.
Design
Review
Authors
Loading...
Metabolic targeting for regeneration requires clinical validation; leaves open its role in human heart failure pending dedicated trials.
Effect estimate: null (95% CI null)
p-value: p=null
Understanding the mechanisms that regulate cardiac metabolism is key to unlocking metabolic interventions for heart failure and promoting adult heart regeneration.
Bae et al. (2021) conducted a review in Heart failure and regeneration. null vs. null was evaluated on Promotion of heart regeneration via targeted metabolism (null, 95% CI null, p=null). Targeting metabolism, such as through CPT1 inhibition, shows potential for improving cardiac regeneration following injury, but current evidence from animal studies lacks strong clinical trial data with specific metrics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: